FolioLanternBeta
BDXBecton Dickinson

Michael Garrison

EVP & Pres Med.Essntl&BioPharm at Becton Dickinson, as of Jun 25, 2026Sold $784K of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
13K
shares held after the latest filing, Becton Dickinson
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
4.4K
shares sold, past 12 months
4
days with sales
$334K
largest single day, Jan 15, 2026
1
company filed for

Share of stake sold at Becton Dickinson is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDec 2025: $123K under a disclosed planDecJan 2026: $334K under a disclosed plan$334KJanFebMarAprMayJun 2026: $327K under a disclosed planJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Becton Dickinson (BDX)EVP & Pres Med.Essntl&BioPharmSep 14, 2022Jun 25, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.